THC Biomed Intl Ltd

PINK:THCBF USA Drug Manufacturers - Specialty & Generic
Market Cap
$163.94K
Market Cap Rank
#40663 Global
#13188 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$2.24
About

THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under t… Read more

THC Biomed Intl Ltd - Asset Resilience Ratio

Latest as of January 2020: 0.00%

THC Biomed Intl Ltd (THCBF) has an Asset Resilience Ratio of 0.00% as of January 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$0.00
Cash + Short-term Investments
Total Assets
$21.09 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2004–2019)

This chart shows how THC Biomed Intl Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down THC Biomed Intl Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: THC Biomed Intl Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

THC Biomed Intl Ltd Industry Peers by Asset Resilience Ratio

Compare THC Biomed Intl Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for THC Biomed Intl Ltd (2004–2019)

The table below shows the annual Asset Resilience Ratio data for THC Biomed Intl Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-07-31 0.00% $0.00 $18.06 Million --
2018-07-31 0.00% $0.00 $14.48 Million --
2016-07-31 0.00% $0.00 $1.60 Million --
2015-07-31 0.25% $3.15K $1.27 Million +0.10pp
2008-07-31 0.14% $5.70K $3.96 Million -0.34pp
2007-07-31 0.49% $19.80K $4.08 Million -0.39pp
2006-07-31 0.88% $26.40K $3.01 Million +0.14pp
2005-07-31 0.74% $22.75K $3.09 Million +0.48pp
2004-07-31 0.26% $8.00K $3.12 Million --
pp = percentage points